This single institution retrospective study evaluated outcomes of valve replacement for degenerated bioprosthetic aortic valves comparing surgical AVR (SAVR) to transcatheter valve-in-valve procedures (TViV). Patients were matched into 2 groups of 22 according to STS risk scores. Operative mortality, stroke rate, and 3-year survival were similar between the groups.
You are here:
Reoperative Surgical Aortic Valve Replacement Versus Transcatheter Valve-in-Valve Replacement for Degenerated Bioprosthetic Aortic Valves
Submitted by: Mark Ferguson
Source: Annals of Thoracic Surgery
Keywords:
Author(s): Julius I. Ejiofor, Maroun Yammine, Morgan T. Harloff, Siobhan McGurk, Jochen D. Muehlschlegel, Prem S. Shekar, Lawrence H. Cohn, Pinak Shah, Tsuyoshi Kaneko
